Xiaomeng Huang
- Cancer Research top 5%
- MicroRNA in disease regulation 13
- Cancer Genomics and Diagnostics 8
- Molecular Biology top 10%
- RNA Interference and Gene Delivery 11
- Advanced biosensing and bioanalysis techniques 9
- Single-cell and spatial transcriptomics 3
- Hematology top 10%
- Acute Myeloid Leukemia Research 4
- Biomaterials top 10%
- Biotechnology top 10%
-
- Chronic Lymphocytic Leukemia Research 7
-
- Berberine and alkaloids research 3
Xiaomeng Huang
39 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 89
- Cancer Research 340
- Molecular Biology 748
- Hematology 102
- Biomaterials 93
- Biotechnology 51
Countries citing papers authored by Xiaomeng Huang
This map shows the geographic impact of Xiaomeng Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomeng Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomeng Huang more than expected).
Fields of papers citing papers by Xiaomeng Huang
This network shows the impact of papers produced by Xiaomeng Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomeng Huang. The network helps show where Xiaomeng Huang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaomeng Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 0 | |
| 7 | 2021 | 1 | |
| 8 | 2018 | 5 | |
| 9 | 2018 | 38 | |
| 10 | 2017 | 2 | |
| 11 | 2017 | 18 | |
| 12 | 2016 | 13 | |
| 13 | 2016 | 11 | |
| 14 | 2015 | 85 | |
| 15 | Targeted Delivery of MicroRNAs by Nanoparticles: A Novel Therapeutic Strategy in Acute Myeloid Leukemia | 2014 | 1 |
| 16 | 2014 | 57 | |
| 17 | 2014 | 87 | |
| 18 | 2014 | 39 | |
| 19 | 2013 | 151 | |
| 20 | 2011 | 24 |
About Xiaomeng Huang
Xiaomeng Huang is a scholar working on Cancer Research, Genetics and Molecular Biology, having authored 46 papers that have together received 1.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (13 papers), RNA Interference and Gene Delivery (11 papers), Advanced biosensing and bioanalysis techniques (9 papers), Cancer Genomics and Diagnostics (8 papers), Chronic Lymphocytic Leukemia Research (7 papers), Acute Myeloid Leukemia Research (4 papers), Single-cell and spatial transcriptomics (3 papers) and Berberine and alkaloids research (3 papers). The work is most often cited by research in Cancer Research (340 citations), Molecular Biology (748 citations) and Hematology (102 citations). Xiaomeng Huang has collaborated with scholars based in United States, China and Poland. Frequent co-authors include Guido Marcucci, Robert J. Lee, Ramiro Garzon, Clara D. Bloomfield, Michael A. Caligiuri, Ly James Lee, Ramasamy Santhanam, Bo Yu, Xinmei Wang and Sebastian Schwind. Their work appears in journals such as Proceedings of the National Academy of Sciences, Blood and Bioinformatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.